ORG 10172 vs heparin in preventing deep-vein thrombosis in patients with acute ischemic stroke.

Completed

Phase N/A Results

Summary of Purpose

To compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis (DVT) in patients with acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Multicenter, double-blind, randomized trial of 179 patients at 5 centers.

Contacts

Not available